CRDF
Cardiff Oncology Inc
Price:
2.81
USD
Volume:
602,197
United States | Biotechnology
Cardiff Gross Margin
As of 2025-05-19, the Gross Margin of Cardiff Oncology Inc (CRDF) is 100%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Cardiff Gross Margin - Historical Value
| Date | Value |
|---|---|
| 2024-12-31 | 100% |
| 2023-12-31 | - |
| 2022-12-31 | - |
| 2021-12-31 | - |
| 2020-12-31 | - |
| 2019-12-31 | 100% |
| 2018-12-31 | -57.9% |
| 2017-12-31 | -254.9% |
| 2016-12-31 | -355.3% |
| 2015-12-31 | -103.2% |
Cardiff Gross Margin - Peers Comparison